img

Global Kidney Transplant Rejection Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Kidney Transplant Rejection Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Kidney Transplant Rejection Therapeutics report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Kidney Transplant Rejection Therapeutics market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Kidney Transplant Rejection Therapeutics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Kidney Transplant Rejection Therapeutics key manufacturers include CSL Limited, Digna Biotech, S.L., GlaxoSmithKline Plc, Grifols, S.A., Hansa Medical AB, Kyowa Hakko Kirin, Mabtech Limited, Magnus Life Ltd and Noorik Biopharmaceuticals AG, etc. CSL Limited, Digna Biotech, S.L., GlaxoSmithKline Plc are top 3 players and held % sales share in total in 2022.
Kidney Transplant Rejection Therapeutics can be divided into Azathioprine, Cortina, Cyclophosphamide and Cyclosporin A, etc. Azathioprine is the mainstream product in the market, accounting for % sales share globally in 2022.
Kidney Transplant Rejection Therapeutics is widely used in various fields, such as Hospital, Clinic, ASCs and Others, etc. Hospital provides greatest supports to the Kidney Transplant Rejection Therapeutics industry development. In 2022, global % sales of Kidney Transplant Rejection Therapeutics went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Kidney Transplant Rejection Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


CSL Limited
Digna Biotech, S.L.
GlaxoSmithKline Plc
Grifols, S.A.
Hansa Medical AB
Kyowa Hakko Kirin
Mabtech Limited
Magnus Life Ltd
Noorik Biopharmaceuticals AG
Novartis AG
Opsona Therapeutics Limited
OSE Immunotherapeutics
Pharmicell
Pharming Group N.V.
Segment by Type
Azathioprine
Cortina
Cyclophosphamide
Cyclosporin A
Other

Segment by Application


Hospital
Clinic
ASCs
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Kidney Transplant Rejection Therapeutics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Kidney Transplant Rejection Therapeutics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Kidney Transplant Rejection Therapeutics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Kidney Transplant Rejection Therapeutics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Kidney Transplant Rejection Therapeutics introduction, etc. Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Kidney Transplant Rejection Therapeutics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Kidney Transplant Rejection Therapeutics Market Overview
1.1 Kidney Transplant Rejection Therapeutics Product Overview
1.2 Kidney Transplant Rejection Therapeutics Market Segment by Type
1.2.1 Azathioprine
1.2.2 Cortina
1.2.3 Cyclophosphamide
1.2.4 Cyclosporin A
1.2.5 Other
1.3 Global Kidney Transplant Rejection Therapeutics Market Size by Type
1.3.1 Global Kidney Transplant Rejection Therapeutics Market Size Overview by Type (2018-2034)
1.3.2 Global Kidney Transplant Rejection Therapeutics Historic Market Size Review by Type (2018-2024)
1.3.3 Global Kidney Transplant Rejection Therapeutics Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Kidney Transplant Rejection Therapeutics Sales Breakdown by Type (2018-2024)
1.4.2 Europe Kidney Transplant Rejection Therapeutics Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Kidney Transplant Rejection Therapeutics Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Kidney Transplant Rejection Therapeutics Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Kidney Transplant Rejection Therapeutics Sales Breakdown by Type (2018-2024)
2 Global Kidney Transplant Rejection Therapeutics Market Competition by Company
2.1 Global Top Players by Kidney Transplant Rejection Therapeutics Sales (2018-2024)
2.2 Global Top Players by Kidney Transplant Rejection Therapeutics Revenue (2018-2024)
2.3 Global Top Players by Kidney Transplant Rejection Therapeutics Price (2018-2024)
2.4 Global Top Manufacturers Kidney Transplant Rejection Therapeutics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Kidney Transplant Rejection Therapeutics Market Competitive Situation and Trends
2.5.1 Kidney Transplant Rejection Therapeutics Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Kidney Transplant Rejection Therapeutics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Kidney Transplant Rejection Therapeutics as of 2022)
2.7 Date of Key Manufacturers Enter into Kidney Transplant Rejection Therapeutics Market
2.8 Key Manufacturers Kidney Transplant Rejection Therapeutics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Kidney Transplant Rejection Therapeutics Status and Outlook by Region
3.1 Global Kidney Transplant Rejection Therapeutics Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Kidney Transplant Rejection Therapeutics Historic Market Size by Region
3.2.1 Global Kidney Transplant Rejection Therapeutics Sales in Volume by Region (2018-2024)
3.2.2 Global Kidney Transplant Rejection Therapeutics Sales in Value by Region (2018-2024)
3.2.3 Global Kidney Transplant Rejection Therapeutics Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Kidney Transplant Rejection Therapeutics Forecasted Market Size by Region
3.3.1 Global Kidney Transplant Rejection Therapeutics Sales in Volume by Region (2024-2034)
3.3.2 Global Kidney Transplant Rejection Therapeutics Sales in Value by Region (2024-2034)
3.3.3 Global Kidney Transplant Rejection Therapeutics Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Kidney Transplant Rejection Therapeutics by Application
4.1 Kidney Transplant Rejection Therapeutics Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 ASCs
4.1.4 Others
4.2 Global Kidney Transplant Rejection Therapeutics Market Size by Application
4.2.1 Global Kidney Transplant Rejection Therapeutics Market Size Overview by Application (2018-2034)
4.2.2 Global Kidney Transplant Rejection Therapeutics Historic Market Size Review by Application (2018-2024)
4.2.3 Global Kidney Transplant Rejection Therapeutics Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Kidney Transplant Rejection Therapeutics Sales Breakdown by Application (2018-2024)
4.3.2 Europe Kidney Transplant Rejection Therapeutics Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Kidney Transplant Rejection Therapeutics Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Kidney Transplant Rejection Therapeutics Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Kidney Transplant Rejection Therapeutics Sales Breakdown by Application (2018-2024)
5 North America Kidney Transplant Rejection Therapeutics by Country
5.1 North America Kidney Transplant Rejection Therapeutics Historic Market Size by Country
5.1.1 North America Kidney Transplant Rejection Therapeutics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Kidney Transplant Rejection Therapeutics Sales in Volume by Country (2018-2024)
5.1.3 North America Kidney Transplant Rejection Therapeutics Sales in Value by Country (2018-2024)
5.2 North America Kidney Transplant Rejection Therapeutics Forecasted Market Size by Country
5.2.1 North America Kidney Transplant Rejection Therapeutics Sales in Volume by Country (2024-2034)
5.2.2 North America Kidney Transplant Rejection Therapeutics Sales in Value by Country (2024-2034)
6 Europe Kidney Transplant Rejection Therapeutics by Country
6.1 Europe Kidney Transplant Rejection Therapeutics Historic Market Size by Country
6.1.1 Europe Kidney Transplant Rejection Therapeutics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Kidney Transplant Rejection Therapeutics Sales in Volume by Country (2018-2024)
6.1.3 Europe Kidney Transplant Rejection Therapeutics Sales in Value by Country (2018-2024)
6.2 Europe Kidney Transplant Rejection Therapeutics Forecasted Market Size by Country
6.2.1 Europe Kidney Transplant Rejection Therapeutics Sales in Volume by Country (2024-2034)
6.2.2 Europe Kidney Transplant Rejection Therapeutics Sales in Value by Country (2024-2034)
7 Asia-Pacific Kidney Transplant Rejection Therapeutics by Region
7.1 Asia-Pacific Kidney Transplant Rejection Therapeutics Historic Market Size by Region
7.1.1 Asia-Pacific Kidney Transplant Rejection Therapeutics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Kidney Transplant Rejection Therapeutics Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Kidney Transplant Rejection Therapeutics Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Kidney Transplant Rejection Therapeutics Forecasted Market Size by Region
7.2.1 Asia-Pacific Kidney Transplant Rejection Therapeutics Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Kidney Transplant Rejection Therapeutics Sales in Value by Region (2024-2034)
8 Latin America Kidney Transplant Rejection Therapeutics by Country
8.1 Latin America Kidney Transplant Rejection Therapeutics Historic Market Size by Country
8.1.1 Latin America Kidney Transplant Rejection Therapeutics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Kidney Transplant Rejection Therapeutics Sales in Volume by Country (2018-2024)
8.1.3 Latin America Kidney Transplant Rejection Therapeutics Sales in Value by Country (2018-2024)
8.2 Latin America Kidney Transplant Rejection Therapeutics Forecasted Market Size by Country
8.2.1 Latin America Kidney Transplant Rejection Therapeutics Sales in Volume by Country (2024-2034)
8.2.2 Latin America Kidney Transplant Rejection Therapeutics Sales in Value by Country (2024-2034)
9 Middle East and Africa Kidney Transplant Rejection Therapeutics by Country
9.1 Middle East and Africa Kidney Transplant Rejection Therapeutics Historic Market Size by Country
9.1.1 Middle East and Africa Kidney Transplant Rejection Therapeutics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Kidney Transplant Rejection Therapeutics Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Kidney Transplant Rejection Therapeutics Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Kidney Transplant Rejection Therapeutics Forecasted Market Size by Country
9.2.1 Middle East and Africa Kidney Transplant Rejection Therapeutics Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Kidney Transplant Rejection Therapeutics Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 CSL Limited
10.1.1 CSL Limited Company Information
10.1.2 CSL Limited Introduction and Business Overview
10.1.3 CSL Limited Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.1.4 CSL Limited Kidney Transplant Rejection Therapeutics Products Offered
10.1.5 CSL Limited Recent Development
10.2 Digna Biotech, S.L.
10.2.1 Digna Biotech, S.L. Company Information
10.2.2 Digna Biotech, S.L. Introduction and Business Overview
10.2.3 Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Products Offered
10.2.5 Digna Biotech, S.L. Recent Development
10.3 GlaxoSmithKline Plc
10.3.1 GlaxoSmithKline Plc Company Information
10.3.2 GlaxoSmithKline Plc Introduction and Business Overview
10.3.3 GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.3.4 GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Products Offered
10.3.5 GlaxoSmithKline Plc Recent Development
10.4 Grifols, S.A.
10.4.1 Grifols, S.A. Company Information
10.4.2 Grifols, S.A. Introduction and Business Overview
10.4.3 Grifols, S.A. Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Grifols, S.A. Kidney Transplant Rejection Therapeutics Products Offered
10.4.5 Grifols, S.A. Recent Development
10.5 Hansa Medical AB
10.5.1 Hansa Medical AB Company Information
10.5.2 Hansa Medical AB Introduction and Business Overview
10.5.3 Hansa Medical AB Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Hansa Medical AB Kidney Transplant Rejection Therapeutics Products Offered
10.5.5 Hansa Medical AB Recent Development
10.6 Kyowa Hakko Kirin
10.6.1 Kyowa Hakko Kirin Company Information
10.6.2 Kyowa Hakko Kirin Introduction and Business Overview
10.6.3 Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Products Offered
10.6.5 Kyowa Hakko Kirin Recent Development
10.7 Mabtech Limited
10.7.1 Mabtech Limited Company Information
10.7.2 Mabtech Limited Introduction and Business Overview
10.7.3 Mabtech Limited Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Mabtech Limited Kidney Transplant Rejection Therapeutics Products Offered
10.7.5 Mabtech Limited Recent Development
10.8 Magnus Life Ltd
10.8.1 Magnus Life Ltd Company Information
10.8.2 Magnus Life Ltd Introduction and Business Overview
10.8.3 Magnus Life Ltd Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Magnus Life Ltd Kidney Transplant Rejection Therapeutics Products Offered
10.8.5 Magnus Life Ltd Recent Development
10.9 Noorik Biopharmaceuticals AG
10.9.1 Noorik Biopharmaceuticals AG Company Information
10.9.2 Noorik Biopharmaceuticals AG Introduction and Business Overview
10.9.3 Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Products Offered
10.9.5 Noorik Biopharmaceuticals AG Recent Development
10.10 Novartis AG
10.10.1 Novartis AG Company Information
10.10.2 Novartis AG Introduction and Business Overview
10.10.3 Novartis AG Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Novartis AG Kidney Transplant Rejection Therapeutics Products Offered
10.10.5 Novartis AG Recent Development
10.11 Opsona Therapeutics Limited
10.11.1 Opsona Therapeutics Limited Company Information
10.11.2 Opsona Therapeutics Limited Introduction and Business Overview
10.11.3 Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Products Offered
10.11.5 Opsona Therapeutics Limited Recent Development
10.12 OSE Immunotherapeutics
10.12.1 OSE Immunotherapeutics Company Information
10.12.2 OSE Immunotherapeutics Introduction and Business Overview
10.12.3 OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.12.4 OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Products Offered
10.12.5 OSE Immunotherapeutics Recent Development
10.13 Pharmicell
10.13.1 Pharmicell Company Information
10.13.2 Pharmicell Introduction and Business Overview
10.13.3 Pharmicell Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Pharmicell Kidney Transplant Rejection Therapeutics Products Offered
10.13.5 Pharmicell Recent Development
10.14 Pharming Group N.V.
10.14.1 Pharming Group N.V. Company Information
10.14.2 Pharming Group N.V. Introduction and Business Overview
10.14.3 Pharming Group N.V. Kidney Transplant Rejection Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Pharming Group N.V. Kidney Transplant Rejection Therapeutics Products Offered
10.14.5 Pharming Group N.V. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Kidney Transplant Rejection Therapeutics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Kidney Transplant Rejection Therapeutics Industrial Chain Analysis
11.4 Kidney Transplant Rejection Therapeutics Market Dynamics
11.4.1 Kidney Transplant Rejection Therapeutics Industry Trends
11.4.2 Kidney Transplant Rejection Therapeutics Market Drivers
11.4.3 Kidney Transplant Rejection Therapeutics Market Challenges
11.4.4 Kidney Transplant Rejection Therapeutics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Kidney Transplant Rejection Therapeutics Distributors
12.3 Kidney Transplant Rejection Therapeutics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Azathioprine
Table 2. Major Company of Cortina
Table 3. Major Company of Cyclophosphamide
Table 4. Major Company of Cyclosporin A
Table 5. Major Company of Other
Table 6. Global Kidney Transplant Rejection Therapeutics Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Kidney Transplant Rejection Therapeutics Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Kidney Transplant Rejection Therapeutics Sales by Type (2018-2024) & (US& Million)
Table 10. Global Kidney Transplant Rejection Therapeutics Market Share in Value by Type (2018-2024)
Table 11. Global Kidney Transplant Rejection Therapeutics Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Kidney Transplant Rejection Therapeutics Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Kidney Transplant Rejection Therapeutics Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Type (2024-2034)
Table 16. Global Kidney Transplant Rejection Therapeutics Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Kidney Transplant Rejection Therapeutics Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Kidney Transplant Rejection Therapeutics Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Kidney Transplant Rejection Therapeutics Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Kidney Transplant Rejection Therapeutics Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Kidney Transplant Rejection Therapeutics Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Kidney Transplant Rejection Therapeutics Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Kidney Transplant Rejection Therapeutics Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Kidney Transplant Rejection Therapeutics Sales Share by Company (2018-2024)
Table 29. Global Kidney Transplant Rejection Therapeutics Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Kidney Transplant Rejection Therapeutics Revenue Share by Company (2018-2024)
Table 31. Global Market Kidney Transplant Rejection Therapeutics Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Kidney Transplant Rejection Therapeutics Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Kidney Transplant Rejection Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Kidney Transplant Rejection Therapeutics as of 2022)
Table 35. Date of Key Manufacturers Enter into Kidney Transplant Rejection Therapeutics Market
Table 36. Key Manufacturers Kidney Transplant Rejection Therapeutics Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Kidney Transplant Rejection Therapeutics Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Kidney Transplant Rejection Therapeutics Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Kidney Transplant Rejection Therapeutics Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Region (2018-2024)
Table 43. Global Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Kidney Transplant Rejection Therapeutics Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Kidney Transplant Rejection Therapeutics Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Region (2024-2034)
Table 48. Global Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Kidney Transplant Rejection Therapeutics Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Kidney Transplant Rejection Therapeutics Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Kidney Transplant Rejection Therapeutics Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Application (2018-2024)
Table 54. Global Kidney Transplant Rejection Therapeutics Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Kidney Transplant Rejection Therapeutics Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Kidney Transplant Rejection Therapeutics Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Application (2024-2034)
Table 59. Global Kidney Transplant Rejection Therapeutics Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Kidney Transplant Rejection Therapeutics Sales by Application (2018-2024) (K Pcs)
Table 61. North America Kidney Transplant Rejection Therapeutics Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Kidney Transplant Rejection Therapeutics Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Kidney Transplant Rejection Therapeutics Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Kidney Transplant Rejection Therapeutics Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Kidney Transplant Rejection Therapeutics Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Kidney Transplant Rejection Therapeutics Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Kidney Transplant Rejection Therapeutics Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Country (2018-2024)
Table 74. North America Kidney Transplant Rejection Therapeutics Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Kidney Transplant Rejection Therapeutics Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Kidney Transplant Rejection Therapeutics Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Kidney Transplant Rejection Therapeutics Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Kidney Transplant Rejection Therapeutics Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Kidney Transplant Rejection Therapeutics Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Kidney Transplant Rejection Therapeutics Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Kidney Transplant Rejection Therapeutics Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Kidney Transplant Rejection Therapeutics Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Kidney Transplant Rejection Therapeutics Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Country (2024-2034)
Table 110. CSL Limited Company Information
Table 111. CSL Limited Introduction and Business Overview
Table 112. CSL Limited Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. CSL Limited Kidney Transplant Rejection Therapeutics Product
Table 114. CSL Limited Recent Development
Table 115. Digna Biotech, S.L. Company Information
Table 116. Digna Biotech, S.L. Introduction and Business Overview
Table 117. Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Product
Table 119. Digna Biotech, S.L. Recent Development
Table 120. GlaxoSmithKline Plc Company Information
Table 121. GlaxoSmithKline Plc Introduction and Business Overview
Table 122. GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Product
Table 124. GlaxoSmithKline Plc Recent Development
Table 125. Grifols, S.A. Company Information
Table 126. Grifols, S.A. Introduction and Business Overview
Table 127. Grifols, S.A. Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Grifols, S.A. Kidney Transplant Rejection Therapeutics Product
Table 129. Grifols, S.A. Recent Development
Table 130. Hansa Medical AB Company Information
Table 131. Hansa Medical AB Introduction and Business Overview
Table 132. Hansa Medical AB Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Hansa Medical AB Kidney Transplant Rejection Therapeutics Product
Table 134. Hansa Medical AB Recent Development
Table 135. Kyowa Hakko Kirin Company Information
Table 136. Kyowa Hakko Kirin Introduction and Business Overview
Table 137. Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Product
Table 139. Kyowa Hakko Kirin Recent Development
Table 140. Mabtech Limited Company Information
Table 141. Mabtech Limited Introduction and Business Overview
Table 142. Mabtech Limited Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Mabtech Limited Kidney Transplant Rejection Therapeutics Product
Table 144. Mabtech Limited Recent Development
Table 145. Magnus Life Ltd Company Information
Table 146. Magnus Life Ltd Introduction and Business Overview
Table 147. Magnus Life Ltd Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. Magnus Life Ltd Kidney Transplant Rejection Therapeutics Product
Table 149. Magnus Life Ltd Recent Development
Table 150. Noorik Biopharmaceuticals AG Company Information
Table 151. Noorik Biopharmaceuticals AG Introduction and Business Overview
Table 152. Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 153. Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Product
Table 154. Noorik Biopharmaceuticals AG Recent Development
Table 155. Novartis AG Company Information
Table 156. Novartis AG Introduction and Business Overview
Table 157. Novartis AG Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 158. Novartis AG Kidney Transplant Rejection Therapeutics Product
Table 159. Novartis AG Recent Development
Table 160. Opsona Therapeutics Limited Company Information
Table 161. Opsona Therapeutics Limited Introduction and Business Overview
Table 162. Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 163. Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Product
Table 164. Opsona Therapeutics Limited Recent Development
Table 165. OSE Immunotherapeutics Company Information
Table 166. OSE Immunotherapeutics Introduction and Business Overview
Table 167. OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 168. OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Product
Table 169. OSE Immunotherapeutics Recent Development
Table 170. Pharmicell Company Information
Table 171. Pharmicell Introduction and Business Overview
Table 172. Pharmicell Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 173. Pharmicell Kidney Transplant Rejection Therapeutics Product
Table 174. Pharmicell Recent Development
Table 175. Pharming Group N.V. Company Information
Table 176. Pharming Group N.V. Introduction and Business Overview
Table 177. Pharming Group N.V. Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 178. Pharming Group N.V. Kidney Transplant Rejection Therapeutics Product
Table 179. Pharming Group N.V. Recent Development
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Kidney Transplant Rejection Therapeutics Market Trends
Table 183. Kidney Transplant Rejection Therapeutics Market Drivers
Table 184. Kidney Transplant Rejection Therapeutics Market Challenges
Table 185. Kidney Transplant Rejection Therapeutics Market Restraints
Table 186. Kidney Transplant Rejection Therapeutics Distributors List
Table 187. Kidney Transplant Rejection Therapeutics Downstream Customers
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Kidney Transplant Rejection Therapeutics Product Picture
Figure 2. Global Kidney Transplant Rejection Therapeutics Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Kidney Transplant Rejection Therapeutics Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Kidney Transplant Rejection Therapeutics Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Azathioprine
Figure 6. Global Azathioprine Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Cortina
Figure 8. Global Cortina Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Cyclophosphamide
Figure 10. Global Cyclophosphamide Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Cyclosporin A
Figure 12. Global Cyclosporin A Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Other
Figure 14. Global Other Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Kidney Transplant Rejection Therapeutics Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type in 2022 & 2034
Figure 17. North America Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Type in 2022
Figure 18. North America Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Type in 2022
Figure 19. Europe Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Type in 2022
Figure 20. Europe Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Type in 2022
Figure 23. Latin America Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Kidney Transplant Rejection Therapeutics Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Kidney Transplant Rejection Therapeutics Revenue in 2022
Figure 29. Kidney Transplant Rejection Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Hospital
Figure 31. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Clinic
Figure 33. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of ASCs
Figure 35. Global ASCs Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Global Kidney Transplant Rejection Therapeutics Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application in 2022 & 2034
Figure 40. North America Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Application in 2022
Figure 41. North America Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Application in 2022
Figure 42. Europe Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Application in 2022
Figure 43. Europe Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Application in 2022
Figure 46. Latin America Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Kidney Transplant Rejection Therapeutics Manufacturing Cost Structure
Figure 51. Kidney Transplant Rejection Therapeutics Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries